The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines.

Paxillin, a member of the group 3 subfamily of LIM domain proteins, is localized within focal adhesions and participates in a number of signal transduction pathways mobilized upon activation of cell surface receptors. In recent years, a number of group 3 LIM domain proteins have been found to also localize within the nucleus and exert direct effects on transcription. We show here that paxillin is present within nuclei and can target the nuclear matrix of CV-1 cells, cultured prostate cancer cell lines, and human prostate tissue. The increased targeting of androgen receptor to the nuclear matrix upon overexpression of paxillin may be brought about by direct interactions between paxillin and the receptor, which were detected in vitro. Paxillin functions as a coactivator for androgen receptor and glucocorticoid receptor, but not estrogen receptor alpha, similar to its close relative Hic-5/ARA55. Both paxillin and Hic-5/ARA55 use their COOH-terminal LIM domain to interact with steroid receptors. However, paxillin is distinguished from Hic-5/ARA55 by both the location of its receptor coactivation domain (i.e., COOH-terminal LIM domain) and by the dominant-negative activity of its NH(2)-terminal domain. Thus, highly related group 3 LIM domain proteins may use distinct mechanisms to modulate steroid hormone receptor transactivation.

[1]  D. Longo,et al.  Linking β-Catenin to Androgen-signaling Pathway* , 2002, The Journal of Biological Chemistry.

[2]  J. C. Belmonte,et al.  RLIM inhibits functional activity of LIM homeodomain transcription factors via recruitment of the histone deacetylase complex , 1999, Nature Genetics.

[3]  V. Ogryzko,et al.  p300 and p300/cAMP-response Element-binding Protein-associated Factor Acetylate the Androgen Receptor at Sites Governing Hormone-dependent Transactivation* , 2000, The Journal of Biological Chemistry.

[4]  P. Sassone-Corsi,et al.  A Family of LIM-Only Transcriptional Coactivators: Tissue-Specific Expression and Selective Activation of CREB and CREM , 2000, Molecular and Cellular Biology.

[5]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[6]  F. Claessens,et al.  The Androgen Receptor Amino-Terminal Domain Plays a Key Role in p160 Coactivator-Stimulated Gene Transcription , 1999, Molecular and Cellular Biology.

[7]  W. Pratt,et al.  Steroid receptor interactions with heat shock protein and immunophilin chaperones. , 1997, Endocrine reviews.

[8]  F. Saatcioglu,et al.  DNA Binding-independent Transcriptional Activation by the Androgen Receptor through Triggering of Coactivators* , 2001, The Journal of Biological Chemistry.

[9]  G. Jenster,et al.  Domains of the human androgen receptor and glucocorticoid receptor involved in binding to the nuclear matrix , 1995, Journal of cellular biochemistry.

[10]  F. Claessens,et al.  The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1 , 1999, Molecular and Cellular Biology.

[11]  Chawnshang Chang,et al.  Isolation and Characterization of ARA160 as the First Androgen Receptor N-terminal-associated Coactivator in Human Prostate Cells* , 1999, The Journal of Biological Chemistry.

[12]  L. Bégin,et al.  Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma , 1996, International journal of cancer.

[13]  S. Yeh,et al.  Cloning and Characterization of Human Prostate Coactivator ARA54, a Novel Protein That Associates with the Androgen Receptor* , 1999, The Journal of Biological Chemistry.

[14]  M. Rosenfeld,et al.  A family of LIM domain-associated cofactors confer transcriptional synergism between LIM and Otx homeodomain proteins. , 1997, Genes & development.

[15]  A W Partin,et al.  Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. , 1993, Cancer research.

[16]  Chawnshang Chang,et al.  The androgen receptor: a mediator of diverse responses. , 1996, Frontiers in bioscience : a journal and virtual library.

[17]  P. Sawchenko,et al.  P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Wilson,et al.  The FXXLF Motif Mediates Androgen Receptor-specific Interactions with Coregulators* , 2002, The Journal of Biological Chemistry.

[19]  H. A. Louis,et al.  Structure of the carboxy-terminal LIM domain from the cysteine rich protein CRP , 1994, Nature Structural Biology.

[20]  Sheila M. Thomas,et al.  The Adaptor Protein Paxillin Is Essential for Normal Development in the Mouse and Is a Critical Transducer of Fibronectin Signaling , 2002, Molecular and Cellular Biology.

[21]  K. Nose,et al.  Induction of senescence-like phenotypes by forced expression of hic-5, which encodes a novel LIM motif protein, in immortalized human fibroblasts , 1997, Molecular and cellular biology.

[22]  H. Marie,et al.  Ajuba, a cytosolic LIM protein, shuttles into the nucleus and affects embryonal cell proliferation and fate decisions. , 2000, Molecular biology of the cell.

[23]  T. Gilmore,et al.  Characterization of mouse Trip6: a putative intracellular signaling protein. , 1999, Gene.

[24]  G. Jenster,et al.  The role of the androgen receptor in the development and progression of prostate cancer. , 1999, Seminars in oncology.

[25]  S. Chevalier,et al.  Bombesin stimulates the motility of human prostate‐carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin‐associated proteins , 1997, International journal of cancer.

[26]  T. Kouzarides,et al.  Regulation of E2F1 activity by acetylation , 2000, The EMBO journal.

[27]  A. Steinmetz,et al.  Classification of LIM proteins. , 1995, Trends in genetics : TIG.

[28]  J. J. Breen,et al.  LIM domains: multiple roles as adapters and functional modifiers in protein interactions. , 1998, Trends in genetics : TIG.

[29]  C. Glass,et al.  The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.

[30]  R. Maurer,et al.  MRG1 Binds to the LIM Domain of Lhx2 and May Function as a Coactivator to Stimulate Glycoprotein Hormone α-Subunit Gene Expression* , 1999, The Journal of Biological Chemistry.

[31]  F. Dilworth,et al.  Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription , 2001, Oncogene.

[32]  D. DeFranco,et al.  Interaction of the tau2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix. , 2000, Molecular biology of the cell.

[33]  H. Gronemeyer,et al.  Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. , 2000, Trends in pharmacological sciences.

[34]  R A Irvine,et al.  Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor. , 2000, Cancer research.

[35]  Andrew J. Bannister,et al.  The CBP co-activator is a histone acetyltransferase , 1996, Nature.

[36]  K. Kamiguchi,et al.  Interaction of Hic-5, A Senescence-related Protein, with Focal Adhesion Kinase* , 1998, The Journal of Biological Chemistry.

[37]  J. Morley,et al.  Biological actions of androgens. , 1987, Endocrine reviews.

[38]  W. Figg,et al.  The androgen receptor: genetic considerations in the development and treatment of prostate cancer , 1999, Journal of Molecular Medicine.

[39]  W. V. D. Van de Ven,et al.  LPP, an actin cytoskeleton protein related to zyxin, harbors a nuclear export signal and transcriptional activation capacity. , 2000, Molecular biology of the cell.

[40]  M. Evans,et al.  The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development , 1994, Cell.

[41]  M. Tsai,et al.  The Angelman Syndrome-Associated Protein, E6-AP, Is a Coactivator for the Nuclear Hormone Receptor Superfamily , 1999, Molecular and Cellular Biology.

[42]  S. Takahashi,et al.  Cell Adhesion Kinase β Forms a Complex with a New Member, Hic-5, of Proteins Localized at Focal Adhesions* , 1998, The Journal of Biological Chemistry.

[43]  C. Turner.  Paxillin and focal adhesion signalling , 2000, Nature Cell Biology.

[44]  K. Matsumoto,et al.  The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant. , 2001, Biochemical and biophysical research communications.

[45]  R. Schüle,et al.  FHL2, a novel tissue‐specific coactivator of the androgen receptor , 2000, The EMBO journal.

[46]  D. Aswad,et al.  Regulation of transcription by a protein methyltransferase. , 1999, Science.

[47]  Sheila M. Thomas,et al.  Characterization of a focal adhesion protein, Hic-5, that shares extensive homology with paxillin. , 1999, Journal of cell science.

[48]  V. Ogryzko,et al.  Regulation of activity of the transcription factor GATA-1 by acetylation , 1998, Nature.

[49]  David A. Nix,et al.  Nuclear–Cytoplasmic Shuttling of the Focal Contact Protein, Zyxin: A Potential Mechanism for Communication between Sites of Cell Adhesion and the Nucleus , 1997, The Journal of cell biology.

[50]  M. Garabedian,et al.  GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors , 1997, Molecular and cellular biology.

[51]  D. DeFranco,et al.  The DNA-binding and tau2 transactivation domains of the rat glucocorticoid receptor constitute a nuclear matrix-targeting signal. , 1998, Molecular endocrinology.

[52]  R. Brent,et al.  Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. , 1995, Molecular endocrinology.

[53]  Chawnshang Chang,et al.  From Androgen Receptor to the General Transcription Factor TFIIH , 2000, The Journal of Biological Chemistry.

[54]  S. Inui,et al.  Cloning and Characterization of Androgen Receptor Coactivator, ARA55, in Human Prostate* , 1999, The Journal of Biological Chemistry.

[55]  M. Beckerle,et al.  LIM domain-containing protein trip6 can act as a coactivator for the v-Rel transcription factor. , 1999, Gene expression.

[56]  B. Howard,et al.  The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.

[57]  T. Rabbitts,et al.  The LIM‐only protein Lmo2 is a bridging molecule assembling an erythroid, DNA‐binding complex which includes the TAL1, E47, GATA‐1 and Ldb1/NLI proteins , 1997, The EMBO journal.

[58]  S. Tsai,et al.  Cdc25B Functions as a Novel Coactivator for the Steroid Receptors , 2001, Molecular and Cellular Biology.

[59]  Marc Montminy,et al.  A Transcriptional Switch Mediated by Cofactor Methylation , 2001, Science.

[60]  Michael D Schaller,et al.  Paxillin: a focal adhesion-associated adaptor protein , 2001, Oncogene.

[61]  E. Barrack.  The nuclear matrix of the prostate contains acceptor sites for androgen receptors. , 1983, Endocrinology.

[62]  T. Gilmore,et al.  LIM domain protein Trip6 has a conserved nuclear export signal, nuclear targeting sequences, and multiple transactivation domains. , 2001, Biochimica et biophysica acta.